Comment on Most patients taking Wegovy and Ozempic weight-loss drugs stop within two years

Most patients taking Wegovy and Ozempic weight-loss drugs stop within two years

Evidence that many people may stop using the weight-loss therapies not long after starting is influencing a debate over their cost to patients, employers, and government health plans. Only one in four U.S. patients prescribed Novo Nordisk’s Wegovy or Ozempic for weight loss were still taking the popular medications two years later, according to an analysis of U.S.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News